Skip to content

The ability of the steep ramp test to measure and monitor aerobic capacity

Criterion validity and responsiveness of the steep ramp test to evaluate aerobic capacity in cancer survivors participating in a supervised exercise rehabilitation program

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN10373531
Enrollment
50
Registered
2020-09-15
Start date
2019-01-01
Completion date
Unknown
Last updated
2021-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aerobic capacity in cancer survivors Not Applicable

Interventions

Cancer survivors attending a 10-week supervised exercise rehabilitation program at Maastricht UMC+ are included in the study. Participants perform a cardiopulmonary exercise test (CPET) and a steep ra

Sponsors

Maastricht University Medical Centre
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Cancer survivors of 18 years and older, who: 1.1. Participate in the multidisciplinary oncology rehabilitation program at the Department of Physical Therapy of the Maastricht University Medical Center (UMC+) 1.2. Complete a CPET and SRT before the start of the exercise program (T=0) 1.3. Give written informed consent for the use of their usual care performance data

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
1. VO2peak measured during CPET (CPET-VO2peak) using cardiopulmonary exercise testing (CPET) performed on an electronically braked cycle ergometer (Lode Corival Rehab, Lode BV, Groningen, the Netherlands) where continuous breath-by-breath analysis was obtained during the test using an ergospirometry system calibrated for respiratory gas analysis (Vyntus CPX, CareFusion, Hochberg, Germany) measured at basline (T0) and 10 weeks (T1) 2. Peak work rate achieved during the steep ramp test (SRT-WRpeak) using an electronically braked cycle ergometer (Lode Corival Rehab Lode BV, Groningen, the Netherlands) measured at basline (T0) and 10 weeks (T1)

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026